ASX Announcements

Change of Director's Interest Notice
Investor presentation, 15 June 2021
Initial Director's Interest Notice
Neuren CEO Jon Pilcher appointed to board of directors
Neuren to present at MST Access investor conference
Update - Annual General Meeting 2021
Positive FDA meetings enable INDs for three Phase 2 trials
Virtual AGM online guide
Notice of Annual General Meeting/Proxy Form
New patent issued to 2032 for Neuren's trofinetide in Canada